Safety Assessment of Leronlimab and Its Effect on Brain Inflammation in Alzheimer's Disease

Clinical trial NCT07553338 · RECRUITING

Trial details

NCT number: NCT07553338
Sponsor: Weill Medical College of Cornell University
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Mild Cognitive Impairment (MCI) Due to Alzheimer's Disease Alzheimer's Disease

Start date: 2026-04-30
Primary completion: 2027-11-01
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.